Origen de la red de primer grado Isabelle Degbegni.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
21
| Public Company | Biotechnology | 21 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Isabelle Degbegni a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Public Communications Contact | |
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal | |
NOVO NORDISK A/S | Pharmaceuticals: Major | Human Resources Officer | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
Novo Nordisk Pharma GmbH
Novo Nordisk Pharma GmbH Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma GmbH manufacturers and distributes pharmaceutical products. It offers pharmaceutical products for diabetes, menopause, growth hormones and blood clotting which treats chronic diseases: hemophilia, growth disorders and obesity. The company was founded in 1991 and is headquartered in Mainz, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Henley Business School Ltd. | College/University | Masters Business Admin | |
ABBVIE INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Syntimmune, Inc.
Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member President | |
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland. | Pharmaceuticals: Generic | Chief Tech/Sci/R&D Officer | |
Universität zu Köln | College/University | Graduate Degree | |
Trinity College Dublin | College/University | Graduate Degree | |
HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Human Resources Officer | |
Georgetown University | College/University | Undergraduate Degree | |
University College London | College/University | Doctorate Degree | |
Freie Universität Berlin | College/University | Graduate Degree | |
The Johannes Gutenberg University of Mainz | College/University | Doctorate Degree Doctorate Degree | |
École Normale Supérieure | College/University | Graduate Degree | |
Ludwig-Maximilians-Universität München | College/University | Graduate Degree | |
VIVORYON THERAPEUTICS N.V. | Biotechnology | Director/Board Member | |
Humboldt-Universität zu Berlin | College/University | Graduate Degree | |
Novo Nordisk SAS
Novo Nordisk SAS Pharmaceuticals: MajorHealth Technology Novo Nordisk SAS manufactures pharmaceutical drugs. It produces and sells medicines for the treatment of diabetes, haemophilia, and hormonal disease. The company was founded in 1959 and is headquartered in Paris, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
QUANTUM GENOMICS | Pharmaceuticals: Major | Director/Board Member | |
Spinnaker Topco Ltd. | Director/Board Member | ||
Novartis Austria GmbH
Novartis Austria GmbH Pharmaceuticals: MajorHealth Technology Novartis Austria GmbH operates as a holding company, which engages in the development and production of pharmaceutical products. The company was founded on January 30, 2006 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Sanofi Pasteur MSD SNC
Sanofi Pasteur MSD SNC Pharmaceuticals: MajorHealth Technology Sanofi Pasteur MSD SNC is engaged in the wholesale of pharmaceutical products. The company was founded on August 16, 1993 and is headquartered in Lyon, France. | Pharmaceuticals: Major | Chief Executive Officer | |
Diaverum AB
Diaverum AB Medical/Nursing ServicesHealth Services Diaverum AB engages in the provision of renal care to patients with chronic kidney disease (CKD). It offers hemodialysis, peritoneal dialysis, and kidney transplant. The company was founded by Nils Alwall in 1991 and is headquartered in Malmo, Sweden. | Medical/Nursing Services | Director/Board Member | |
Dublin City University | College/University | Undergraduate Degree | |
University of Antwerp | College/University | Graduate Degree | |
Duale Hochschule Baden-Württemberg Mannheim | College/University | Undergraduate Degree | |
NIOX GROUP PLC | Medical/Nursing Services | Director/Board Member | |
Columbia University College of Physicians & Surgeons | College/University | Doctorate Degree | |
BIODEXA PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director/Board Member | |
PIERIS PHARMACEUTICALS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | Pharmaceuticals: Major | Director/Board Member | |
AUTOLUS THERAPEUTICS PLC | Biotechnology | Director of Finance/CFO | |
AKERO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Novo Nordisk SA (Belgium) | Corporate Officer/Principal | ||
Pharmacia & Upjohn
Pharmacia & Upjohn Pharmaceuticals: MajorHealth Technology Pharmacia & Upjohn is a Belgian company that manufactures pharmaceutical products. The private company is based in Brussels, Belgium. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Faculté De Médecine Necker Enfants Malades Université | College/University | Doctorate Degree | |
VERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Boys & Girls Clubs of Metro Los Angeles
Boys & Girls Clubs of Metro Los Angeles Miscellaneous Commercial ServicesCommercial Services Boys & Girls Clubs of Metro Los Angeles is a non-profit organization that was founded in December 2015 to provide a sustainable solution to the opportunity crises facing vulnerable children in the neediest neighborhoods of Los Angeles. Boys & Girls Clubs of Metro Los Angeles is based in Los Angeles, CA, and has subsidiaries in the United States. The organization operates four clubs in Bell Gardens, Challengers, Downs, and Willowbrook, and offers nationally recognized, research-based programs and activities in three core areas: academic success, good character and citizenship, and healthy lifestyles. The organization empowers youth to explore a future with endless possibilities by offering creative programming, such as new approaches to science, technology, engineering, and math (STEM) created in collaboration with community partners. The non-profit company was founded in 2015, and the CEO is Patrick Mahoney. | Miscellaneous Commercial Services | Director/Board Member | |
ALVOTECH | Biotechnology | Director/Board Member | |
Human Immunology Biosciences, Inc.
Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Human Immunology Biosciences, Inc. is a company based in South San Francisco, CA. Human Immunology Biosciences, Inc. was founded by Travis Murdoch, who has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
Schreiner Medipharm | President | ||
CAT Capital Topco Ltd. | Director/Board Member |
Estadísticas
Internacional
Estados Unidos | 16 |
Alemania | 12 |
Reino Unido | 7 |
Francia | 7 |
Bélgica | 4 |
Sectorial
Health Technology | 29 |
Consumer Services | 16 |
Health Services | 3 |
Commercial Services | 2 |
Operativa
Director/Board Member | 52 |
Corporate Officer/Principal | 36 |
Independent Dir/Board Member | 18 |
Chairman | 11 |
Chief Tech/Sci/R&D Officer | 8 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Isabelle Degbegni
- Conexiones Empresas